Goldman Sachs Group Inc Liquidia Corp Transaction History

Goldman Sachs Group Inc

$780 Billion
Q3 2025

A detailed history of Goldman Sachs Group Inc transactions in Liquidia Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 2,782,285 shares of LQDA stock, worth $79.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,782,285

Previous 2,417,005 15.11%

Holding current value

$79.5 Million

Previous $30.1 Million 112.03%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$12.06 - $28.85 $4.41 Million - $10.5 Million	365,280 Added 15.11%	2,782,285 $63.9 Million
Q2 2025 Aug 14, 2025	BUY	$11.99 - $19.3 $18.7 Million - $30 Million	1,555,774 Added 180.65%	2,417,005 $30.1 Million
Q1 2025 May 09, 2025	BUY	$11.36 - $16.5 $942,368 - $1.37 Million	82,955 Added 10.66%	861,231 $12.7 Million
Q4 2024 Feb 11, 2025	BUY	$9.82 - $11.8 $5.08 Million - $6.11 Million	517,809 Added 198.8%	778,276 $9.15 Million
Q3 2024 Nov 14, 2024	BUY	$8.9 - $14.11 $835,683 - $1.32 Million	93,897 Added 56.37%	260,467 $2.6 Million
Q2 2024 Aug 13, 2024	SELL	$11.96 - $15.71 $1.17 Million - $1.54 Million	-97,891 Reduced 37.02%	166,570 $2 Million
Q1 2024 May 15, 2024	SELL	$11.35 - $16.73 $1.91 Million - $2.81 Million	-167,895 Reduced 38.83%	264,461 $3.9 Million
Q4 2023 Feb 13, 2024	BUY	$5.77 - $12.19 $1.81 Million - $3.83 Million	313,975 Added 265.22%	432,356 $5.2 Million
Q3 2023 May 14, 2024	SELL	$6.27 - $8.15 $1.97 Million - $2.56 Million	-313,975 Reduced 72.62%	118,381 $750,000
Q3 2023 Nov 14, 2023	SELL	$6.27 - $8.15 $137,482 - $178,705	-21,927 Reduced 15.63%	118,381 $750,000
Q2 2023 May 14, 2024	SELL	$6.63 - $9.9 $172,194 - $257,122	-25,972 Reduced 15.62%	140,308 $1.1 Million
Q2 2023 Aug 14, 2023	SELL	$6.63 - $9.9 $172,194 - $257,122	-25,972 Reduced 15.62%	140,308 $1.1 Million
Q1 2023 May 14, 2024	SELL	$5.72 - $7.91 $194,640 - $269,161	-34,028 Reduced 16.99%	166,280 $1.15 Million
Q1 2023 May 11, 2023	SELL	$5.72 - $7.91 $194,640 - $269,161	-34,028 Reduced 16.99%	166,280 $1.15 Million
Q4 2022 May 14, 2024	SELL	$4.68 - $6.54 $553,606 - $773,629	-118,292 Reduced 37.13%	200,308 $1.28 Million
Q4 2022 Feb 13, 2023	SELL	$4.68 - $6.54 $553,606 - $773,629	-118,292 Reduced 37.13%	200,308 $1.28 Million
Q3 2022 May 14, 2024	BUY	$3.73 - $8.39 $977,651 - $2.2 Million	262,105 Added 463.94%	318,600 $1.73 Million
Q3 2022 Nov 10, 2022	BUY	$3.73 - $8.39 $977,651 - $2.2 Million	262,105 Added 463.94%	318,600 $1.73 Million
Q2 2022 May 14, 2024	SELL	$3.37 - $7.55 $1.27 Million - $2.84 Million	-375,861 Reduced 86.93%	56,495 $246,000
Q2 2022 Aug 15, 2022	SELL	$3.37 - $7.55 $200,511 - $449,217	-59,499 Reduced 51.29%	56,495 $246,000
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $502,455 - $721,424	97,754 Added 535.93%	115,994 $832,000
Q4 2021 Feb 14, 2022	BUY	$2.71 - $5.17 $6,929 - $13,219	2,557 Added 16.3%	18,240 $89,000
Q3 2021 Nov 10, 2021	BUY	$2.28 - $2.95 $35,757 - $46,264	15,683 New	15,683 $43,000

Others Institutions Holding LQDA

# of Institutions

235

Shares Held

54M

Call Options Held

6.33M

Put Options Held

7.87M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $1.84B
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Liquidia Corp Transaction History